JNJ vs BAX
By Alex · Tickerpine
Johnson & Johnson vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BAX |
|---|---|---|
| Price | $285.75 | $25.81 |
| Market cap | $687.89B | $13.35B |
| P/E ratio | 43.4 | — |
| ROE | 20.02% | -9.04% |
| Profit margin | 16.20% | -6.23% |
| Revenue growth | 5.90% | 5.00% |
| Dividend yield | 1.88% | 0.16% |
| Beta | 0.20 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BAX in plain English
- JNJ is the bigger company — about 51.5× the market cap of BAX.
- JNJ earns a higher return on equity (20% vs -9%).
- JNJ is growing revenue faster (6% vs 5%).
- JNJ has the higher dividend yield (1.88% vs 0.16%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.